A Novel Polyaminocarboxylate Compound To Treat Murine Pulmonary Aspergillosis by Interfering with Zinc Metabolism
Open Access
- 1 June 2018
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (6) , e02510-17
Abstract
Aspergillus fumigatus can cause pulmonary aspergillosis in immunocompromised patients and is associated with a high mortality rate due to a lack of reliable treatment options. This opportunistic pathogen requires zinc in order to grow and cause disease. Novel compounds that interfere with fungal zinc metabolism may therefore be of therapeutic interest. We screened chemical libraries containing 59,223 small molecules using a resazurin assay that compared their effects on an A. fumigatus wild-type strain grown under zinc-limiting conditions and on a zinc transporter knockout strain grown under zinc-replete conditions to identify compounds affecting zinc metabolism. After a first screen, 116 molecules were selected whose inhibitory effects on fungal growth were further tested by using luminescence assays and hyphal length measurements to confirm their activity, as well as by toxicity assays on HeLa cells and mice. Six compounds were selected following a rescreening, of which two were pyrazolones, two were porphyrins, and two were polyaminocarboxylates. All three groups showed good in vitro activity, but only one of the polyaminocarboxylates was able to significantly improve the survival of immunosuppressed mice suffering from pulmonary aspergillosis. This two-tier screening approach led us to the identification of a novel small molecule with in vivo fungicidal effects and low murine toxicity that may lead to the development of new treatment options for fungal infections by administration of this compound either as a monotherapy or as part of a combination therapy.Keywords
Funding Information
- Institut Pasteur (PTR468)
- Ministerio de Economía y Competitividad (SAF2013-48382-R)
This publication has 48 references indexed in Scilit:
- Potentiometric detection and removal of copper using porphyrinsBMC Chemistry, 2013
- Hidden Killers: Human Fungal InfectionsScience Translational Medicine, 2012
- The Composition of the Culture Medium Influences the β-1,3-Glucan Metabolism of Aspergillus fumigatus and the Antifungal Activity of Inhibitors of β-1,3-Glucan SynthesisAntimicrobial Agents and Chemotherapy, 2012
- Aspergillus fumigatus Survival in Alkaline and Extreme Zinc-Limiting Environments Relies on the Induction of a Zinc Homeostasis System Encoded by the zrfC and aspf2 GenesEukaryotic Cell, 2010
- French/European academic compound library initiativeDrug Discovery Today, 2009
- BioluminescentAspergillus fumigatus, a New Tool for Drug Efficiency Testing and In Vivo Monitoring of Invasive AspergillosisApplied and Environmental Microbiology, 2008
- A porphyrin derivative containing 2-(oxymethyl)pyridine units showing unexpected ratiometric fluorescent recognition of Zn2+ with high selectivityAnalytica Chimica Acta, 2008
- Synthesis and Evaluation of Novel Polyaminocarboxylate-Based Antitumor AgentsJournal of Medicinal Chemistry, 2008
- EDTA as an Adjunct Antifungal Agent for Invasive Pulmonary Aspergillosis in a Rodent ModelAntimicrobial Agents and Chemotherapy, 2006
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999